M-M-RVAXPRO

Powder and solvent for suspension for injection in pre-filled syringe, 1x10exp3 TCID50/0.5ml + 12
RxActive license

Active substance (INN)

measles, mumps and rubella vaccine, live attenuated

Pharmaceutical form

Pharmaceutical formPowder and solvent for suspension for injection in pre-filled syringe
Strength1x10exp3 TCID50/0.5ml + 12
PackagingUkupno 1 bočica sa praškom i 1 napunjeni injekcioni špric sa rastvaračem za suspenziju (1x0.5ml) u kartonskoj kutiji
ManufacturerMerck Sharp & Dohme B.V., Netherlands
Therapeutic groupAnti-infectives for systemic use (J07BD52)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateMarch 15, 2024

Analogs in Montenegro

2

Other medicines with the same active substance

M-M-RVAXPRORx
Powder and solvent for suspension for injection in pre-filled syringe, 1x10exp3 TCID50/0.5ml + 12Merck Sharp & Dohme B.V.
PRIORIXRx
Powder and solvent for solution for injection, 10exp3 CCID50/0.5ml + 10exp3.7 CCID50/0.5ml + 10exp3 CCID50/0.5mlGlaxoSmithKline Biologicals S.A.
Source: CInMED register